Background: Acute otitis media (AOM) is the main reason for physician visits and antibiotic prescriptions in children. Pediatricians (Peds) are gatekeepers for services and sources of information for families. The
Key Words: Acute otitis media, children, national survey, pediatricians, prophylaxis, questionnaire, xylitol Abbreviations: AAFP 5 American Academy of Family Physicians; AAP 5 American Academy of Pediatrics; AOM 5 acute otitis media; ARI 5 acute respiratory infection; CAM 5 complementary and alternative medicine; MEE 5 middle-ear effusion; MH 5 medical home; OME 5 otitis media with effusion; URI 5 upper respiratory infection A ccording to the American Academy of Pediatrics and American Academy of Family Physicians Subcommittee on Management of Acute Otitis Media (AAP/AAFP, 2004), acute otitis media (AOM) is a major health problem throughout the world and one of the most common illnesses and reasons for physician visits in infants and those under 6 yr of age (Daly et al, 2005) . AOM is also the leading cause for antibacterial prescriptions in young children in the United States and has estimated annual costs of about $3-5 billion (Finkelstein et al, 2001; Klein, 2001; AAP/AAFP, 2004; Halasa et al, 2004; Daly et al, 2005; Meropol, 2008; Vouloumanou et al, 2009 ). Conductive hearing loss originating from otitis media can lead to speech, language, socialization, and academic delays if left untreated (Rosenfeld et al, 1997; Klein, 2001; Winskel, 2006) , which should make prevention a high priority.
Family physicians and particularly pediatricians (Peds) are usually the first professionals to see infants and young children for complaints of AOM, and it is important that AOM be diagnosed and differentiated from otitis media with effusion (OME) so that intervention can begin as soon as possible. Physicians who serve as the medical home (MH) for the care of children with AOM and their families play an important role and have major responsibilities in the coordination of communication among audiologists and other stakeholders so that management can begin in a timely fashion. The MH should provide firm, caring, and enthusiastic encouragement and counseling to get families to comply with all providers' recommendations for their children. The MH must provide the necessary authorizations and referrals to appropriate professionals for additional diagnostic and intervention services so that children can receive treatment according to best practices. With that in mind, the AAP/AAFP published the Clinical Practice Guideline: Diagnosis and Management of Acute Otitis Media (referred to here as the "AAP/AAFP guideline") to help physicians with this task. The guideline states that the diagnosis of AOM requires "rapid onset, presence of middle-ear effusion (MEE), and signs and symptoms for middle-ear inflammation" (AAP/AAFP, 2004) . The guideline emphasizes the need for correctly diagnosing and discriminating AOM from OME and normal ear status because it warrants different treatment and management and may lead to inappropriate use of antibacterials.
Treatment for AOM frequently involves antibacterial therapy and/or surgical procedures (e.g., adenoidectomy, tonsillectomy, and tympanostomy tubes), which are somewhat controversial because of their questionable effectiveness, potential for bacteria resistance, and costs (Paradise, 1997; Cantekin, 1998; Kadhim et al, 2007) . Treatment with antibacterial agents is based on the child's age, history of and risk factors for AOM, recent antibacterial use, and parental concerns. The guideline suggested that, unless otherwise indicated (e.g., for patient's age, severe illness, diagnostic uncertainty), physicians should treat initial symptoms (e.g., pain and fever) of AOM within the first 24 hr and use watchful waiting (observation) for 48 to 72 hr before prescribing antibacterials, because most children's infections begin to resolve themselves within the first 24 hr (AAP/AAFP, 2004) . Potential antibiotic resistances and problems with surgery should make the search for low-cost, easy-to-administer, minimalrisk prophylactic alternatives a high priority. Further, the guideline suggested that future research should focus on the prevention of upper respiratory infections (URIs) and subsequent episodes of middle-ear infection.
Peds are primary sources of information and advice for families of children who suffer from AOM. Thus, it is important that Peds are current with the latest prevention and treatment protocols for AOM. The AAP/ AAFP guideline provides physicians with evidencebased clinical practice recommendations for dealing with uncomplicated AOM in otherwise healthy children, 2 mo through 12 yr of age. The guideline provides a specific definition of AOM, addresses pain management and initial observation compared to antibiotic therapy, appropriate choices of antimicrobials, and steps for prevention. Although physicians are not bound to using the guideline, it does represent the current standard of care for AOM in otherwise healthy children and can serve as a reference to gauge how they practice for this disorder.
The guideline provides physicians with recommendations, options, or no recommendations on six aspects of AOM: (1) a recommendation to diagnose AOM by confirming a history of acute onset, identifying signs of MEE, and evaluating for the presence of signs and symptoms of middle-ear inflammation; (2) a strong recommendation for the management of AOM to include assessment of pain and treatment to reduce it; (3a) an option for observation without use of antibacterial agents for selected children with uncomplicated AOM based on diagnostic certainty, age, illness severity, and assurance of follow-up; (3b) a recommendation that when a decision is made to treat with antibacterials, clinicians should initially prescribe amoxicillin for most children; (4) a recommendation that if children fail to respond to initial management within 48 to 72 hr, then clinicians must reassess to confirm AOM to exclude other illnesses, and if AOM is confirmed, then children initially managed with observation should follow with antibacterial therapy while those initially managed with antibacterials should have the agent changed; (5) a recommendation that clinicians should encourage prevention of AOM by reducing risk factors; and (6) no recommendation for sufficient evidence supporting the use of complementary and alternative medicine (CAM) for AOM. These six areas can be used to assess how physicians practice for AOM in children. Two earlier studies (Vernacchio et al, 2006 (Vernacchio et al, , 2007a surveyed family physicians participating within the Slone Center OfficeBased Research Network and focused primarily on their adherence to the guideline's recommendations for use of antibiotic therapies and the observation option. Vernacchio et al (2007a) found that their physicians' practices with specific drugs used for different scenarios varied somewhat from the guideline's recommendations. Although their physicians generally accepted the observation option, they only used it occasionally, mainly because of parental pressures on them to provide antibiotics. Vernacchio et al (2007a) reported that the physicians strongly perceived that parents would not be willing to accept the observation option, but that recent success at reducing antibiotic use could change that with education for both physicians and families.
Although possibly limited in their effectiveness, parents can monitor their children for symptoms of acute respiratory infections (ARIs) and try to reduce risk factors for AOM by breast-feeding during the first 6 mo of life (Daly et al, 1997) , reducing pacifier use in the second 6 mo of life (Niemela et al, 2000) , avoiding supine bottle-feeding or "bottle propping" (Brown and Magnuson, 2000) , and eliminating direct and/or passive inhalation of tobacco smoke (Etzel et al, 1992; Ilicali et al, 1999 ). Other prophylactic strategies may limit common pathogens for AOM including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis (Klein, 1994) . Kouwen and DeJonckere (2007) reported that regular use of chewing gum can reduce the chance of having OME in children by 40%. Unfortunately, the authors stated that they missed information about which specific types of chewing gum were given to the children.
Xylitol is a sugar alcohol that has been shown to be a low-risk, cost-effective prophylaxis for AOM that parents can use with their children via chewing gum (Uhari et al, 1996) . Xylitol is a naturally occurring sweetener produced from birch trees and a variety of berries. It is a five-carbon polyol that was first discovered by French and German chemists in the 1890s. It is currently used as an alternative sweetener (having about one-third fewer calories than regular sugar) and a prophylaxis against dental caries (Makinen et al, 1995) . The U.S. Food and Drug Administration approved xylitol in 1963 for "special dietary purposes" (Milgrom et al, 2006) , and by 1983 the Joint Expert Committee on Food Additives authorized it as a safe sweetener for foods (Joint Expert Committee on Food Additives, 1983). Xylitol is available in a variety of candies, chewing gums, lozenges, syrups, toothpastes, mouthwashes, and other products (Uhari et al, 1996; Burt, 2006) and is widely used by the U.S. dental industry for caries prevention.
Two double-blinded, randomized, controlled clinical trials (Uhari et al, 1996 (Uhari et al, , 1998 in Finland have shown its relative effectiveness for preventing AOM in a significantly greater proportion of otherwise healthy young children than when compared to a control group (Uhari et al, 1996 (Uhari et al, , 1998 . The treatment groups were administered xylitol five times a day in chewing gum or in syrup given after meals and snacks resulting in a daily cumulative dosage of 8 to 10 g/day of xylitol while the control groups received a placebo (Uhari et al, 1996 (Uhari et al, , 1998 . However, the Finnish researchers completed two other clinical trials and found that alterations in specified dosages (Hautalahti et al, 2007) and/or administration to children already having ARIs (Tapiainen et al, 2002) failed to demonstrate the same prophylactic effect for xylitol. Nevertheless, the results at a high level of evidence from two high-quality double-blinded randomized, controlled clinical trials, considered to be the "gold standard" of medical research (Cox, 2005) , strongly suggest that xylitol is an effective prophylactic when administered to healthy children in the specified dosages.
Moreover, xylitol also appears to have few if any side effects (Uhari et al, 1996 (Uhari et al, , 1998 Vernacchio et al, 2007b; Sezen et al, 2008) , is easily administered to and tolerated by young children (Vernacchio et al, 2007b) , is a low-risk and low-cost alternative to antibiotics and tympanostomy tubes when appropriate, and seems to be a prophylaxis worthy of further investigation. Failure to harness the prophylactic potential of xylitol for AOM seems counterintuitive given the current focus in the United States on containment of health-care costs through prevention of diseases. This may be due in part to physicians' adherence to the AAP/AAFP guideline, and their knowledge and opinions about xylitol use with children.
Prevention of AOM should also be of interest to audiologists who provide audiological testing and nonmedical follow-up to monitor middle-ear function and hearing sensitivity for patients once physicians initiate their medical diagnosis and treatment. Clinical audiologists may even see children with AOM before Peds or otolaryngologists as a result of referrals from speech-language pathologists and/or family physicians who are concerned about possible hearing loss causing communication delays. Thus, audiologists often face families of children with AOM or OME and can be involved with the nonmedical monitoring of the status of the illness to determine if conductive hearing loss is present and if medical interventions by physicians are effective. Otoscopic examination, pure-tone air-and bone-conduction audiometry, immittance, and otoacoustic emissions are part of the battery of tests typically used by most audiologists and some physicians in diagnosing and monitoring AOM. Some audiologists also find themselves answering families' questions about treatment options for and implications of AOM in their children.
Because families also seek information from audiologists about prevention of AOM in light of concerns about overuse of antibiotics and tympanostomy tubes, it would be useful for audiologists to know what practices physicians, especially Peds, use in dealing with AOM, and what they believe and do about preventing it in children. It would also be useful to know what physicians believe about and how they practice for preventing AOM in children with regard to nonstandard CAM options like xylitol. Having this information should help clinicians who work with families of children with AOM.
Surveys have been shown to be a good way of obtaining information from physicians about areas of interest to audiologists (e.g., Danhauer et al, 2006 Danhauer et al, , 2009 Johnson et al, 2008 Johnson et al, , 2009a Johnson et al, , 2009b . Therefore, the purposes of this study were to develop and administer a questionnaire to physicians in the United States that would provide information about (1) how Peds practice for AOM relative to the AAP/AAFP guideline and (2) what they believe about, and how they practice for, prevention of AOM in children. The specific questions posed in the present study were these: (1) Do Peds in the United States adhere to the AAP/AAFP guideline in their practice for AOM in children? (2) Do Peds in the United States believe that prevention is a worthwhile effort, and do they use it in managing AOM in children? and (3) Are Peds in the United States generally aware of xylitol as a prophylaxis for AOM in children, do they use it, or would they if data were available to support its use? The University of California Santa Barbara Institutional Review Board approved this project as "exempt" from needing any informed consent from the participants due to the survey nature of the study.
METHODS

Questionnaire
The authors developed and administered the questionnaire for this study using the process described by Cummings and Hulley (2007) to evaluate physicians about their demographic information, adherence to the AAP/AAFP guideline and practice for the diagnosis and management of AOM in children, opinions about preventing AOM in children, and knowledge of and willingness to use xylitol as a prophylaxis for AOM in children. After searching the literature for existing instruments, the authors concluded that none was available that met the needs of the present study and that it was necessary to design a new questionnaire. Although Vernacchio et al (2006 Vernacchio et al ( , 2007a surveyed physicians about the AAP/AAFP guideline, their questionnaires were not included in their publications, and they focused on different aspects of the recommendations than did the present study, which also assessed Peds' knowledge about and use of xylitol. Lee et al (2009) developed a questionnaire for use with physicians in Nova Scotia regarding the epidemiology, diagnosis, and management of otitis media, but the actual instrument was not provided in the publication. The questionnaire, however, was inappropriate for use in this study because it had a different scope and focused on health practices and service delivery models outside the United States.
Thus, we listed variables to be covered, composed several drafts, revised, shortened, pretested, and validated a new questionnaire. Several iterations of the questionnaire were revised with additions, modifications, and omission of items based on input from colleagues, physicians, and pilot testing on groups of Peds in Santa Barbara, California, and in Auburn, Alabama. The feedback received from them was used to reword for increased clarity, rearrange response options and formats, avoid potential ambiguities, and drop certain items. The questionnaire was designed and pretested to be able to be completed in about 10 min in order to be sensitive to physicians' busy schedules and to enhance chances of getting them to return it.
Questions in the first section of the questionnaire inquired about demographic information relevant to the Peds and their practices. Questions in the second section were developed from the six recommendations covered in the AAP/AAFP guideline (listed earlier) to assess how closely physicians followed them in their practices with children. Questions in the final section assessed the Peds' knowledge about xylitol as a prophylaxis for AOM, whether they used (or would use) it with children in their practices and if they wished to receive further information about xylitol. Items included space for participants to respond by writing in answers, selecting an appropriate option, indicating yes or no, and checking their degree of agreement with statements. The final 48-item questionnaire is shown in the Appendix.
Participants
Potential participants were Peds randomly selected from throughout the United States. The physician pool was restricted to the United States because possible differences in medical practices and service-delivery models in other countries might have confused the results. A random sample of Peds in the United States was determined using the following process to ensure external validity. Potential states for sampling were drawn from the nine geographic divisions of the United States (see Table 1 ) identified by the U.S. Census Bureau (2000) in order to help ensure the likelihood that all areas of the country could be represented for each of two mailings. One state was randomly selected from those in each division. Then the three cities having the largest populations (U.S. Census Bureau, 2000) in each of the nine states were identified, and one city was randomly selected from each of the nine states. This process provided each of the nine divisions a substantially populated city within a state that had each been randomly selected. The names and addresses of all Peds practicing within an 8.5 mile radius of each city center were selected from yellowpages.com for possible participation in the survey. This process was repeated for the second mailing, except that states and cities randomly selected for the first mailing were not considered. Thus, two states and two cities for each division were selected as seen on Table 1 . This random process resulted in 506 Peds who were used as the potential participant pool to whom surveys were mailed.
Procedure
A cover letter with instructions for completing the survey and a self-addressed, stamped return envelope were enclosed with the questionnaire and mailed to potential participants. Though confidentiality was ensured, the outside envelope, the return envelope, and the questionnaire were all coded corresponding to a master sheet containing the names and addresses of the Peds. This was done to make sure that records were kept of who responded with what answers if this information ever needed to be uncovered. Respondents were encouraged to write in comments on the questionnaire if necessary to elaborate on their answers. Potential participants were informed that their responses would be kept anonymous and that only group data would be reported in any dissemination of their answers. For convenience, half of the surveys were mailed to potential participants on May 20, 2009, with a return cutoff date of June 2, 2009; the other half was mailed on June 3, 2009, with a return cutoff date of June 17, 2009. A total of 506 surveys were mailed to potential participants. Peds self-selected their consent for participation in the study by simply returning the questionnaires.
Data Management
The information from the returned questionnaires was entered onto an Excel spreadsheet used to track data entry. The information from the useable questionnaires was then entered into Survey Monkey, an online system for immediate tracking and analyses of data. Two of the authors (T.S. and J.S.) entered the data and cross-checked each other's entries with 100% accuracy before the analyses were conducted. The participants' responses to each item of the questionnaire are shown in the Appendix. The possible number of participants responding to each question was 98; however, some of them skipped certain items as noted. Also, if participants responded "no" to item 36, then they were Pediatricians, Acute Otitis Media, and Xylitol/Danhauer et al instructed to go directly to item 45. Because the Peds' responses to the questions are self-explanatory from inspection of the Appendix, a discussion of each item is not presented here; rather, pertinent data are interpreted for those that were specifically relevant to the experimental questions posed for this study and the six recommendations from the AAP/AAFP guideline. The percentage of Peds responding to items is rounded here for convenience in data presentation. The Appendix also lists respondents' written comments to items below the questions, and they are accounted for in the results and discussion when appropriate.
RESULTS AND DISCUSSION
Response Rate
Of the 506 questionnaires mailed, 63 were returned to sender by the U.S. postal system because of insufficient addresses, recipients no longer being at that address, or other unknown reasons; 98 were returned useable and included in the analysis. Thus, the response rate was 22% (98 useable/506 mailed 2 63 returned undeliverable). It should be noted that a few returned questionnaires were received after the cutoff dates, and their data were not included in the analyses. This response rate was in line with several earlier studies that have unfortunately shown that physicians are rather notorious for having low compliance for replying to nonmedical, healthrelated surveys (e.g., Cartwright, 1978; McDonald, 1993; Sibbald et al, 1994; Asch et al, 1997; Templeton et al, 1997; Kaner et al, 1998; Pirotta et al, 1999; Cummings et al, 2001; Danhauer et al, 2006; Hocking et al, 2006; Danhauer et al, 2009; Mathews et al, 2009 ). Response rates for Peds and family physicians responding to questionnaires about newborn hearing screening programs have ranged from about 16 to 85% (Johnson et al, 2009a) . Considerably higher response rates have been obtained for physician-to-physician surveys. For example, in recent studies of otitis media, Vernacchio et al (2007a) achieved a 63% (299 of 477 surveyed) rate from an exclusive group of physicians within the Sloan Center Office-Based Research Network, and Lee et al (2009) garnered a 100% rate for a small, exclusive, convenience sample of 25 family physicians who practiced in the Halifax regional municipality. Those rates for physician-to-physician surveys were dramatically higher thanthe19%obtainedinarecentaudiologist-to-physician study of Peds and early hearing detection and intervention programs, even though it was conducted at a single academic medical center at which some of the authors were employed (Danhauer et al, 2009) . Pirotta and colleagues (1999) found that contacting physicians prior to mailing surveys could improve response rates. Indeed, the studies by Vernacchio et al (2007a) and Lee et al (2009) used exclusive participant pools and repeated mailings, faxes, and telephone calls to participants to achieve their favorable return rates. However, as the authors of those studies noted, even though they had high return rates, the results could have been biased and limited by the samples selected. During pilot testing of the present questionnaire on physicians in Santa Barbara, California, and Auburn, Alabama, we found that neither prior telephone solicitation nor hand-delivering of surveys in person seemed to have had any effect on returns. In fact, in some cases, even when physicians assured us in person that they would return the questionnaires, they failed to do so. Therefore, given the national scope of this study, we elected to mail the surveys to the potential participants without prior solicitation or prompting before the return cutoff period. Although this decision may have affected the return rate, the broad national scope of the survey and the representation of the participants shown in Table 1 should not have biased the results. Earlier, Templeton and colleagues (1997) stated that physicians' low response rates do not necessarily affect the validity of data or indicate that the sample is not representative of the greater population of physicians as long as biases are accounted for in the analyses, which seemed to be the case here.
In any survey, one can never be sure of how those who failed to respond would have affected results if they had replied or what their reasons were for not responding, whether they were due to incorrect addresses and postal delivery problems, busy schedules, lack of interest, refusal to participate, or others. In studies of this nature, there is always a problem that the Peds who were reached and agreed to participate may have had different opinions and practices than those who were not reached or were not interested. However, regardless of the reasons for their participation, the demographic data in the Appendix show that those Peds who did respond were sufficiently well-represented that they should have reduced subject biases from skewing the results.
Demographics
The national scope of this survey was validated by the fact that Peds from all nine divisions of the country responded as noted in Table 1 . However, we caution that the results could be biased toward those Peds practicing in urban locations because the participant pool only included physicians practicing in the largest cities in each of the nine divisions of the United States. Also, for unexplained reasons, only one response was obtained from the West South Central division. About equal numbers of females (53%) and males (47%) responded. Most (75%) of these Peds had been in private practice for over 10 yr. Although this might have biased the results by having Peds who were somewhat older, it should have helped assure that this sample had adequate experience with children having AOM over a number of years and that their responses would reflect changes in diagnosis and management over time, rather than when they attended medical school. Further, the remaining 25% had been in practice for fewer than 10 yr, and their answers should have reflected recent trends in dealing with AOM covered in training programs. Most of the participants (z80%) indicated that a fair portion of their patients under 12 yr of age had at least one bout of AOM per year, which speaks to the prevalence of the disease in question here for this population and the experience that these Peds should have had in dealing with it. As alluded to earlier, it is always difficult to determine whether results of any survey were skewed by having a peculiar type of individuals respond. For example, if only Peds from one section of the country or those who rarely treated children with AOM had responded, then the results could have been biased. The data supported an affirmative answer to this question because the majority (94%) of these Peds either moderately or strongly agreed that they adhered to the AAP/AAFP guideline, which was also reflected in their answers to questions about their practice for AOM. For example, 94% (item 9) routinely assessed and managed more than 76% (item 19) of their patients' pain in the first 24 hr of AOM. Further, although the responses were somewhat less in favor of it than the guideline would like, about 77% (item 20) of these Peds used the watchful waiting/observation option for 50% or fewer of their patients, and 89% (item 27) either moderately or strongly agreed that this procedure was appropriate for selected children. Written comments to item 20 provided additional insights; one encouraged people to use pain management prior to being seen; one said it depended on the age of the child; another stated that most patients have already waited. These comments reflected what many patients do before seeing a physician (i.e., wait to see if symptoms clear themselves). About 61% (item 21) of those who used this procedure checked on their patients within two days of their last appointment. Interestingly, one Ped indicated that if the family did not call back within two days, it was assumed that the problem had resolved. However, this could delay treatment for some children because there are many reasons why families do not return calls, which might be totally unrelated to resolution of the problem. Also, 95% (item 23) of these Peds prescribed amoxicillin as the initial antibacterial for children with AOM and a fever and/or otalgia (two Peds stated that they used decongestants and augmentin), and 88% (item 29) moderately or strongly agreed that children under 6 mo of age suspected of having AOM should be placed on antibacterial therapy. These practices were consistent with the guideline's first four recommendations related to diagnosis and management of AOM in children.
Question 2: Do Peds in the United States Believe That Prevention Is a Worthwhile Effort, and Do They Use it in Managing AOM in Children?
The data also supported an affirmative answer to this question because over 88% (item 10) of these Peds said they encourage prevention of AOM by recommending that families use breast-feeding for at least the first 6 mo and reduce risk factors including eliminating exposure to passive tobacco smoke, avoiding bottle propping, and reducing pacifier use in the second 6 mo of life. Only two of these Peds said they did not do this. Written comments also included using nasal cleansing, reducing home allergens, sitting upright, and making sure that wood stoves and fireplaces are well ventilated. Thus, these Peds' practices were consistent with the guideline's recommendation 5 regarding prevention of AOM. The data relating to this question concerned Peds' responses to the third section of the questionnaire assessing their awareness and use of xylitol and their opinions about it for preventing AOM in children. The data did not support an affirmative answer to this question because only 53% (item 36) of these Peds said they were aware of any medical uses of xylitol. Of those who were, 70% (item 37) were aware of research using xylitol chewing gum to prevent AOM in children, but most (87%, item 38) had not used it with their patients, and 75% (item 40) were not sure if it was effective for that purpose. Likewise, 94% (item 42) were not sure what dosage or in what form (item 41) xylitol should be delivered. Written comments to item 41 indicated that most of the vehicles listed for administration were inappropriate for young children. One Ped wrote in "taffy solutions" as another vehicle. About half (item 43) were not aware of any potential negative side effects of xylitol, while some reported diarrhea and stomach cramping. One written comment suggested choking, and another cited failure to seek medical care. Most of these responses were not surprising considering the issues raised earlier about the lack of xylitol use in this country for AOM. They could also be interpreted as being consistent with the AAP/AAFP guideline recommendation 6, which was that no recommendation could be made for sufficient evidence supporting the use of CAMs for AOM. In fact, 84% (item 24) of these Peds said they did not use CAMs for children under 12 yr of age with AOM, while written comments included oral pain medications, probiotics and antibiotics, and oral and topical analgesics. Further, 86% (item 34) were neutral or moderately or strongly disagreed that CAM is useful in the prevention of AOM. Nevertheless, xylitol is used heavily by the dental profession in the United States for caries prevention and in Finland as a prophylaxis for AOM in children (Uhari et al, 1996 (Uhari et al, , 1998 . These facts, coupled with concerns about traditional treatments and the call for investigations into preventative agents for AOM in recommendation 5 of the AAP/AAFP guideline should encourage more Peds in this country to be open to this option.
About 83% (item 44) of these Peds were neutral or disagreed that they were convinced that xylitol can be used to prevent AOM, yet 68% (item 46) would use or were not sure (29%) if they would use xylitol to prevent AOM in children under 12 yr of age if evidence was available to support it. One Ped commented on item 46 that xylitol is not covered by insurance and can cost about $90 per month, which could be a deterrent for many families. Further, 75% (item 47) said they would like more information about its use with children via article reprints (72%, item 48), the Internet (31%), or e-mail (23%). These responses were more encouraging and suggest a need to make all stakeholders (physicians, audiologists, and families) aware of CAM options like xylitol for prevention of AOM in children. It was also encouraging that 85% (item 33) of these Peds were consistent with the guideline and agreed that research exploring vehicles for the prevention of AOM is worthy of study and financial support. These results suggested that Peds do believe that prevention is a worthwhile effort in managing AOM in children.
Certainly, the blinded, randomized, controlled trials cited earlier suggested that xylitol should be included among CAMs considered more seriously as a prophylaxis for AOM in this country. We find it interesting that the AAP/AAFP guideline commented on measures (e.g., involving breast-feeding, bottle propping, pacifier use, and passive tobacco smoke) that might be taken to prevent AOM in children, and stated that their utility is unclear without even mentioning xylitol, which has been shown to be effective. Although they may be helpful in preventing AOM, it is unclear whether these other measures are evidence based. This issue seemed to be interesting to the Peds in this study as evidenced by item 45, which prompted the most written comments from them regarding the success of various options for preventing AOM. Several of the written comments indicated that none of the options prevent AOM. Unfortunately, even with our careful revisions to and pilot testing of the questionnaire, item 45 was ambiguous as written, and results for it should not be counted heavily here.
Nevertheless, at least one prospective, randomized, single-blinded study (Sezen et al, 2008) has found xylitol chewing gum used in combination with antibiotics to be an effective, well-tolerated, cost-effective CAM for improving middle-ear pressure as part of the management of chronic OME in children. As of early 2009, at least one manufacturer (Arbor Pharmaceuticals, Inc., 2009) began making a xylitol oral solution (Xylarex) commercially available as a medical food product (i.e., FDA approval is not required) by prescription only and under physician supervision for use in dietary management of recurrent AOM. These developments suggest that physicians and pharmaceutical companies are showing a greater interest in xylitol as a CAM for AOM.
Role of Audiologists
Some audiologists might be surprised when viewing these Peds'responsesto item30 for which about80%were neutral or disagreed that audiologists are important team members in contributing to the diagnosis and management of AOM. Nevertheless, the fact that 84% (item 31) of these Peds agreed that AOM reduces the healthrelated quality of life of children, and 66% (item 32) agreed that chronic conductive hearing loss from otitis media negatively impacts children's speech-language development and academic achievement, points to areas where audiologists do have considerable involvement with pediatric patients. Written comments to item 32 suggested that these issues are dependent on families' social class; that they are temporary, if at all; and that they are true for bilateral but not unilateral losses.
Although Peds are the primary caregivers, most pediatric audiologists play a role in counseling families about middle-ear disease and the effects of resulting hearing loss, monitoring progress of medications and surgeries for the ears, and fitting amplification when necessary. This is often important for children from indigent families. Indeed, most of these Peds indicated that a substantial portion of their patients were from indigent families (item 5). It stands to reason that this group might have greater risk for AOM than other segments of society due to factors including: lack of education and access to medical treatment; poor insurance coverage; and increased likelihood of risk factors like exposure to tobacco smoke, higher incidence of respiratory complications (e.g., from allergies, sinus, and asthma), having multiple siblings in the home, and possibly spending time in over-populated day-care centers where colds, flu, and ear infections flourish. This is a group clearly in need of counseling and care who might slip through the cracks in some medical practices if not for audiologists.
Peds' responses regarding diagnostic methods for AOM should be of interest to audiologists in that although the guideline pointed out the need for and difficulty in accurately diagnosing and distinguishing AOM from OME, 87% (item 8) of these Peds moderately or strongly agreed that they find it easy to do so. As expected, 99% (items 11 and 12) routinely used and were comfortable with otoscopy for diagnosing the signs of AOM in children under 12 yr of age. Fewer than half used pneumatic otoscopy (item 13), and over 80% (items 15 through 18) did not use and were not comfortable with tympanometry or acoustic reflectometry. Written comments to item 15 indicated that physicians used tympanometry for follow-up to determine if effusion was present and when the diagnosis was questionable. Clearly, this is an area, especially with tympanometry, where audiologists do provide support for their medical colleagues and make meaningful contributions to the diagnosis and monitoring of children's middle-ear status. Most clinical audiologists spend considerable time monitoring conductive hearing loss, response to antibiotics, and status of tympanostomy tubes in their pediatric patients.
Most of these Peds did not use CAMs in their practice with children, were unaware of any medical uses of xylitol, and had not used it with their patients. They agreed, however, that there is a need for research and vehicles for the prevention of AOM, and they would use xylitol if data were available to support it, and wanted information about it, either in the form of article reprints or by electronic means.
As mentioned earlier, the advent of products like Xylarex, a nonantibiotic requiring a physicians' prescription and supervision, could be part of a xylitol regimen. Alternatively, xylitol is readily available in chewing gum and other nonprescription products, and physicians and audiologists may wish to make their patients aware of them as a possible prophylaxis for AOM.
CONCLUSIONS
T he prevention of highly prevalent diseases (like AOM in children), which have high risks and costs associated with conventional treatments, should be a priority for those managing health care in the United States and throughout the world. The results from this national random sample of Peds in the United States led to the conclusions that most of them adhered to the AAP/AAFP guideline for diagnosing and managing AOM in children, and that although they agreed with the need for prevention and used it in their practices, they were not overwhelmingly involved with CAMs and were generally unaware of xylitol as a prophylaxis for AOM in children. Nevertheless, most of these Peds agreed that they would use xylitol as a prophylaxis for AOM in children if data were available to support a recommendation for its use, and desired more information about it in the form of article reprints or electronically.
Some studies (Uhari et al, 1996 (Uhari et al, , 1998 Vernacchio et al, 2007b; Sezen et al, 2008) have already shown that xylitol is beneficial in preventing AOM. If simply chewing xylitol gum five times a day could prevent AOM and reduce the need for the use of antibiotics and/or surgery, then physicians and audiologists should consider recommending this regimen to families having young children. Future research should continue to investigate and document evidence for the potential use of xylitol and other CAMs for the prevention of AOM in children. Appendix. National Physicians' Acute Otitis Media (AOM) Survey
Please complete this four-page survey about YOUR practice and level of comfort for accurately diagnosing AOM. (Percent and number of respondents answering each item are shown. Also, written comments provided by respondents are shown below each question; specific option elaborated on is shown in parentheses; absence of parentheses indicates that no option was selected and only a written comment was provided). .3 1 8.3 0 0.0 Comments: too age dependent to list; do you mean preventing or treating-very different; lifestyle changes/day care/smoking cessation; not sure all can prevent it; none of these prevent AOM; none of these lasted in prevention; (watchful waiting/observation option): I don't use for prevention of AOM; not to be used unless AOM; (antibiotics): if chronic SOM; (xylitol): have never used; (other): home environmental changes-no smoke-no day care; removal from day care; decrease URIs, decrease smoke exposure; smoke, bottle on back; day care, exposure modification; elimination of tobacco exposure
